We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Danaher Corporation (DHR - Free Report) is a global conglomerate that designs, manufactures and markets diverse lines of professional, medical, industrial, commercial and consumer products. The company organizes its businesses into five operating segments – The Test & Measurement segment, The Environmental segment, The Life Sciences & Diagnostics segment, The Dental segment and Industrial Technologies segment.
The Danaher Business System (‘‘DBS’’), which focuses on critical areas of quality, delivery, cost and innovation, continues to be a key driver of the company’s top line growth. Also the company has significantly expanded its foothold in the healthcare and dental markets over the past few quarters and they are providing solid growth opportunities.
DHR has a decent history in earnings season, with a positive average earnings surprise of 1.20% in the last four trailing quarters.
Currently, DHR has a Zacks Rank #5 (Strong Sell) but that could change following its second quarter 2016 earnings report which has just released. We have highlighted some of the key details from the just-released announcement below:
Earnings: Adjusted earnings per share for the second-quarter 2016 came in at $1.25, which beat the Zacks Consensus Estimate of $1.09.
Revenue: Revenues of $5,785 million missed the Zacks Consensus Estimate of $5,798 million.
Key Stats: Danaher delivered strong second-quarter 2016 results with high-teens adjusted earnings growth, robust operating and free cash flow on the back of its diligently devised business model called the DBS. Though the second-quarter results include operations of Fortive Corporation, it was spun-off on Jul 2, 2016.
Stock Price: Share prices moved up in the pre-market trading probably on account of this healthy beat.
Check back later for our full write up on this DHR earnings report later!
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.Click to get this free report >>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Danaher (DHR) Beats Q2 Earnings, Lags Revenues
Danaher Corporation (DHR - Free Report) is a global conglomerate that designs, manufactures and markets diverse lines of professional, medical, industrial, commercial and consumer products. The company organizes its businesses into five operating segments – The Test & Measurement segment, The Environmental segment, The Life Sciences & Diagnostics segment, The Dental segment and Industrial Technologies segment.
The Danaher Business System (‘‘DBS’’), which focuses on critical areas of quality, delivery, cost and innovation, continues to be a key driver of the company’s top line growth. Also the company has significantly expanded its foothold in the healthcare and dental markets over the past few quarters and they are providing solid growth opportunities.
DHR has a decent history in earnings season, with a positive average earnings surprise of 1.20% in the last four trailing quarters.
Currently, DHR has a Zacks Rank #5 (Strong Sell) but that could change following its second quarter 2016 earnings report which has just released. We have highlighted some of the key details from the just-released announcement below:
Earnings: Adjusted earnings per share for the second-quarter 2016 came in at $1.25, which beat the Zacks Consensus Estimate of $1.09.
DANAHER CORP Price and EPS Surprise
DANAHER CORP Price and EPS Surprise | DANAHER CORP Quote
Revenue: Revenues of $5,785 million missed the Zacks Consensus Estimate of $5,798 million.
Key Stats: Danaher delivered strong second-quarter 2016 results with high-teens adjusted earnings growth, robust operating and free cash flow on the back of its diligently devised business model called the DBS. Though the second-quarter results include operations of Fortive Corporation, it was spun-off on Jul 2, 2016.
Stock Price: Share prices moved up in the pre-market trading probably on account of this healthy beat.
Check back later for our full write up on this DHR earnings report later!
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.Click to get this free report >>